Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | BPS Bioscience, Inc. Announces 3 New Assay Kits for Bromodomain Screening & ProfilingExpanding the Largest Portfolio of Bromodomain Proteins and Assay Kits for a New Class of Epigenetic Drug Targets
Acetylation of lysine residues is a dynamic process that directs gene transcription and chromatin structure. BRD-containing proteins recognize and bind to these acetylated lysines to regulate epigenetically controlled processes. Emerging as a promising new class of targets, BRDs, alongside histone deacetylases (HDACs), acetyltransferases (HATs), methyltransferases (HMTs) and demethylases (HDMs) are important in cancer drug discovery and new treatments for diabetes, neurological disorders, and inflammatory diseases. “These new kits are the latest tools from BPS to support bromodomain drug discovery.” said Suzan Oberle, Senior Director of Sales and Marketing. "In addition to 14 different BRD kits, BPS’s product portfolio includes over 50 proteins containing one or more bromodomains. We offer the most extensive BRD product offering anywhere, and we continue to develop new assays, services, and other specialized solutions to help researchers drive lead compounds through their development pipelines.” BPS is the first company to offer commercially available assay kits for the BRD9, CREBBP and TRIM24 bromodomains. BPS Bioscience aims to make their entire portfolio of high quality bromodomain proteins, assay kits and (+)-JQ1 bromodomain inhibitor easily accessible to all life scientists worldwide. BPS Bioscience plans to release additional bromodomain proteins and assays in the coming months. To learn more about BPS Bioscience’s BRD screening/profiling services please visit http://bpsbioscience.com/ About BPS Bioscience BPS Bioscience, Inc. is a leading manufacturer of Bromodomains, Cytokines, HATs, HDACs, HDMs, HMTs, Kinases, Methyl-Lysine Readers, Phosphatases, Phosphodiesterases, Poly ADP Ribose Polymerases (PARPs), Proteases, and Ubiquitin Enzymes. BPS offers one of the largest selections of recombinant enzymes and assay kits for drug discovery and continues to expand its portfolio of innovative drug discovery products. BPS also provides custom protein expression, biochemical and cell-based assays, and compound screening and profiling services. Headquartered in San Diego, California, BPS has provided products and services to pharmaceutical companies and academic institutes in over 45 countries worldwide. By being at the forefront of technology development, BPS focuses on providing quality life science products and services in a timely manner that will help our customers to accelerate drug discovery and development for treatment of human diseases. Visit BPS’s website for more information: End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|